Announcing the first international, phase 3 MND clinical trial to be offered across multiple locations in New Zealand.

https://www.mndresearch.auckland.ac.nz/2022/08/03/lighthouse-ii-project-triumeq-in-als-mnd/

Sidebar

MND Research Network Newsletters 2022
Best practice guidelines published for MND care in NZ
Prof. Chris Shaw lecture “Gene therapy strategies for MND” available to view now!
Announcing the first international, phase 3 MND clinical trial to be offered across multiple locations in New Zealand.
MND; Who develops it, why, and what we are doing about it?| Webinar
Research Network News
New Zealand genetic frontotemporal dementia study
The 150-year-old mystery disease killing two New Zealanders a week
Motor Neuron Disease Mortality Rates in New Zealand 1992-2013

A novel digital tool for detection and monitoring of amyotrophic lateral sclerosis motor impairment and progression via keystroke dynamics - Monday, July 22, 2024
Muscle Excitability Scale for the assessment of spastic reflexes in spinal cord injury: development and evaluation - Wednesday, July 17, 2024
Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns - Monday, July 8, 2024
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis - Thursday, July 4, 2024
Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS - Friday, June 21, 2024